Actively Recruiting
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
Led by National Cancer Institute, Naples · Updated on 2025-07-29
170
Participants Needed
4
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicentric, retrospective, and prospective biomarker study.
CONDITIONS
Official Title
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 65 18 years
- Candidates for surgical treatment for squamous cell carcinoma of the anus, uterine cervix, vulva, or head-neck region, including microinvasive and invasive carcinomas
- Capable of understanding and willing to sign the informed consent form
- Prospective patients must provide written informed consent before any procedures
You will not qualify if you...
- Presence of metastatic neoplasia
- Receiving treatment for other oncological diseases
- Congenital or acquired immunosuppression, including HIV, organ transplant, or pharmacological immunosuppression
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Istituto Tumori IRCCS Giovanni Paolo II di Bari
Bari, Bari, Italy, 70124
Actively Recruiting
2
Istituto Nazionale Tumori | "Fondazione Pascale"
Naples, Napoli, Italy, 80131
Actively Recruiting
3
Università del Piemonte orientale
Novara, Novara, Italy, 28100
Actively Recruiting
4
Azienda Ospedaliera Universitaria Pisana
Pisa, Pisa, Italy, 56126
Actively Recruiting
Research Team
M
Maria Lina Tornesello, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here